Argentina vs Colombia: The number of people with susceptibility test result for rifampicin
Argentina
36.41
in 2021
Colombia
39.17
in 2021
Argentina rank
127th
Colombia rank
125th
The number of people with susceptibility test result for rifampicin over time
- Argentina
- Colombia
How they compare
Colombia currently reports 39.17 against 36.41 in Argentina, a difference of 2.76.
That makes Colombia's figure about 1.1 times Argentina's.
The two have swapped places 4 times across 5 shared years of data; in 2017 it was Colombia ahead.
Argentina ranks 127th and Colombia ranks 125th of 146 countries.
Argentina has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Argentina | Colombia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 22.37 | 22.03 | 0.3359 | Argentina |
| 2020s | 30.62 | 29.98 | 0.638 | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Argentina or Colombia?
- Colombia, at 39.17 against 36.41 in Argentina as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Argentina and Colombia?
- 2.76, with Colombia ahead.
- How many years of comparable data are there for Argentina and Colombia?
- 5 years are reported by both, from 2017 to 2021.
- How do Argentina and Colombia rank globally for the number of people with susceptibility test result for rifampicin?
- Argentina ranks 127th and Colombia ranks 125th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.